Daily aspirin reduces risk of ovarian cancer, regardless of genetics

Published Date: 08 Mar 2023

New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.

Read Full News

Latest News

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

We can't fact-check our way out of a trust crisis

"This is real protection, and it really applies to all comers," researcher says

News All Time

Studies Raise New Questions in HR-Positive, HER2-Negative Breast Cancer

Experts discuss oral SERDs, novel targeted combinations, and sequencing

FDA Alerts on Shortage of Breast Biopsy Needles

Disruptions likely to persist through 2027, agency says

Why Some Medically Safe Births Still Feel Traumatic

Modern birth narratives may prepare women for control rather than the unpredictability of labor

CIN2 Lesions May Not Need Immediate Treatment

Delaying treatment may reduce unnecessary excisions

T-DXd in Early HER2-Positive Breast Cancer

Experts discuss the DESTINY-Breast11 and DESTINY-Breast05 results in high-risk disease

FDA Approves CDK4/6 Inhibitor for HER2-Positive Breast Cancer

PATINA trial paved the way for palbociclib-based frontline maintenance regimen

Gentler Regimen for HER2+ Breast Cancer Gets Good Grades in 5-Year Report

After neoadjuvant therapy, ctDNA clearance occurred in 96% of patients

TROP2 Drug Wins Two New Indications in Triple-Negative Breast Cancer

Sacituzumab govitecan approved alone or in combination for first-line treatment

Tennis Legend's Cancer's Back; CDC Emails on RFK Jr. Released; Suicide Attempts Down

Health news and commentary gathered by MedPage Today staff

A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say

Abortions in the U.S. have increased dramatically since the Supreme Court overturned Roe v. Wade

Why Does This PCOS Patient Have Painful Vulvovaginal Swelling?

Hint: pay attention to her recent history

Treating Uterine Fibroids While Preserving Fertility

Myomectomy or uterine artery embolization? The debate continues...

Does DESTINY-Breast09 Change First-Line Care in HER2-Positive Breast Cancer?

Experts discuss patient selection and treatment duration of T-DXd

Study Warns on Sedentary Behavior and Cancer Mortality

— Even brief periods of light or moderate physical activity were associated with a reduced risk

Some Women Suffer Posttraumatic Stress After Vaginal Birth

About 1 in 20 women experience persistent or emerging symptoms of posttraumatic stress at 2 months after vaginal delivery, a study finds.

Adverse Childhood Experiences Tied to Higher PMOS Prevalence

Women who experience more difficult or harmful situations in their childhood have a higher prevalence of polyendocrine metabolic ovarian syndrome later in life.

Recommended News For You

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

The September 2018 issue of Medical Bulletin.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Recommended Articles For You

Anemia Symptoms: What You Need to Know  

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options  

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Immune Escape Landscapes in Solid Tumors 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

2.

High numbers of rural patients cross state lines for cancer care

3.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

4.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

5.

Novel biomarkers may improve diagnosis of gallbladder cancer

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care

3.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

4.

The Science Behind Imatinib: How It Targets Cancer Cells 

5.

Progressive Techniques in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot